Cerebrospinal Fluid Cytology-guided Intrathecal Chemo-holiday Therapy for EGFR-positive NSCLC Leptomeningeal Metastases

NCT06861218 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Leptomeningeal Metastases

Interventions

DRUG: pemetrexed
DRUG: vometinib

Sponsor

Zhejiang Cancer Hospital